sitagliptin glp 1 Glucagon-like peptide-1 Sitagliptin/Metformin (Janumet) as Combination Therapy

From Lizzie's insulin resistance to Jackie's journey towards a holistic understanding of metabolic health, we uncover the challenges and triumphs of their experience.

Compare Noom vs

Turkey and Hummus Roll-Up Boxes Lay out slices of deli turkey, spread a thin layer of hummus on each slice, add a strip of cucumber or bell pepper, and roll tightly

However, alternative glucose-lowering therapies are used adjunctively, but importantly are off-label in type 1 diabetes

Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors can reduce CV risk in patients with T2D, and both are recommended by the American Diabetes Association to reduce the risk of major cardiovascular events (MACE)

Updated June 2026